Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. 17 March 2021. Russ Johannesson.

Executive Summary

Glooko raised $30m in a series D and will use the proceeds to expand into new geographies, take advantage of rising reimbursement for digital health, expand solutions for co-morbid conditions and explore tuck-in acquisitions. See what Glooko’s CEO Russ Johannesson said about it here.

“Certainly, [we will expand our sales and marketing groups] with a heavy emphasis on the US market where there have been favorable changes in the reimbursement dynamics for providers, but that’s a trend that’s happening around the globe and we’re taking advantage of that.” – Russ Johannesson, CEO, Glooko

Click here for a free trial of Medtech Insight

Topics

UsernamePublicRestriction

Register

MT143657

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel